Shabir Madhi to Treatment Outcome
This is a "connection" page, showing publications Shabir Madhi has written about Treatment Outcome.
Connection Strength
1,423
-
Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children. J Infect Dis. 2019 09 26; 220(9):1529-1538.
Score: 0,136
-
Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial. Expert Rev Vaccines. 2017 06; 16(6):641-656.
Score: 0,116
-
Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children. Expert Rev Vaccines. 2017 May; 16(5):453-465.
Score: 0,115
-
Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants. Clin Infect Dis. 2016 Jan 15; 62(2):157-65.
Score: 0,103
-
Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial. AIDS. 2013 Jan 28; 27(3):369-79.
Score: 0,086
-
Respiratory viral and pneumococcal coinfection of the respiratory tract: implications of pneumococcal vaccination. Expert Rev Respir Med. 2012 Aug; 6(4):451-65.
Score: 0,083
-
Antibiotic and systemic therapies for pneumonia in human immunodeficiency virus (HIV)-infected and HIV-exposed children. J Infect Dev Ctries. 2012 Feb 13; 6(2):109-19.
Score: 0,080
-
Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program. PLoS One. 2011; 6(11):e27929.
Score: 0,079
-
Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis. 2011 Jan 01; 52(1):128-37.
Score: 0,074
-
Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine. 2007 Mar 22; 25(13):2451-7.
Score: 0,055
-
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20; 388(16):1451-1464.
Score: 0,043
-
Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Clin Infect Dis. 2002 Nov 01; 35(9):1120-6.
Score: 0,042
-
Defining the potential impact of conjugate bacterial polysaccharide-protein vaccines in reducing the burden of pneumonia in human immunodeficiency virus type 1-infected and -uninfected children. Pediatr Infect Dis J. 2002 May; 21(5):393-9.
Score: 0,041
-
Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr Infect Dis J. 2002 Apr; 21(4):291-7.
Score: 0,041
-
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.
Score: 0,037
-
Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials. Lancet Respir Med. 2020 06; 8(6):597-608.
Score: 0,036
-
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis. PLoS Med. 2018 07; 15(7):e1002591.
Score: 0,031
-
Case-control vaccine effectiveness studies: Data collection, analysis and reporting results. Vaccine. 2017 06 05; 35(25):3303-3308.
Score: 0,029
-
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls. Vaccine. 2017 06 05; 35(25):3295-3302.
Score: 0,029
-
Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
Score: 0,028
-
Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study. Int J Tuberc Lung Dis. 2016 08; 20(8):1060-4.
Score: 0,027
-
Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial. Expert Rev Vaccines. 2016 08; 15(8):1055-62.
Score: 0,027
-
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013 Nov 09; 382(9904):1555-63.
Score: 0,023
-
Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS. 2012 Aug 24; 26(13):1685-90.
Score: 0,021
-
Economic burden of acute lower respiratory tract infection in South African children. Paediatr Int Child Health. 2012 May; 32(2):65-73.
Score: 0,020
-
Benefits to mother and child of influenza vaccination during pregnancy. Hum Vaccin Immunother. 2012 Jan; 8(1):130-7.
Score: 0,020